YDS-16801-00910
2 vaccinations
3 coded responses
15 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 727 / AR
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2020-12-23
Registered in v-safe
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2021-01-06
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, NauseaAdult check-in
- 2021-01-16
- 2021-01-17
-
2021-01-21
Survey response — 7 day, dose 2MedDRA: Abortion spontaneous — Feeling: Good · Rash, not including the immediate area around the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-01-26
-
2021-02-02
Survey response — 21 day, dose 2MedDRA: Diarrhoea, Nausea — Feeling: Poor · Be unable to workMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-02-09
Survey response — 28 day, dose 2MedDRA: Sinus disorder — Feeling: PoorMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-02-16
- 2021-02-23
- 2021-04-13
- 2021-07-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech |
Free text
Release 2
Systemic reaction (other): Had miscarriage 4 days after vaccine
Release 3
Symptoms: Nausea and diarrhea
Symptoms: Sinus problems
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Sinus disorder | ✓ | ✓ | ✓ |
| SRO | Abortion spontaneous | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release